Early Response As a Predictor of Long-Term Remission in DMARD-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis Treated with Certolizumab Pegol in Combination with Methotrexate

被引：0
|
作者：
Weinblatt, Michael [1 ]
Bingham, Clifton [2 ]
Burmester, Gerd [3 ]
Bykerk, V. P. [4 ]
Furst, Daniel E. [5 ]
Mariette, Xavier [6 ]
van der Heijde, Desiree [7 ]
Tatla, Daljit [8 ]
Arendt, Catherine [9 ]
Mountian, Irina [10 ]
VanLunen, Brenda [8 ]
Emery, Paul [11 ]
机构：
[1] Brigham & Womens Hosp, Rheumatol Immunol & Allergy, Boston, MA 02115 USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Charite, Dept Rheumatol & Clin Immunol, D-13353 Berlin, Germany
[4] Hosp Special Surg, New York, NY 10021 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Med, Los Angeles, CA 90095 USA
[6] Univ Paris Sud, Hop Univ Paris Sud, AP HP, Paris, France
[7] Univ Hosp, Maastricht, Netherlands
[8] UCB Pharma, Raleigh, NC USA
[9] UCB Pharma, Global Med Affairs, Brussels, Belgium
[10] UCB Pharma, Brussels, Belgium
[11] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1638
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EARLY RESPONSE AS A PREDICTOR OF LONG-TERM CLINICAL RESPONSE IN DMARD-NAIVE PATIENTS WITH SEVERE, ACTIVE AND PROGRESSIVE RA TREATED WITH CERTOLIZUMAB PEGOL PLUS OPTIMIZED MTX VERSUS OPTIMIZED MTX ALONE
    Mariette, X.
    Bingham, C.
    Burmester, G. -R.
    Bykerk, V. P.
    Emery, P.
    Furst, D.
    van der Heijde, D.
    van Vollenhoven, R.
    VanLunen, B.
    Arendt, C.
    Weinblatt, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 242 - 242
  • [2] Certolizumab Pegol in Combination with Methotrexate in DMARD-Naive Patients with Active, Severe, Progressive Rheumatoid Arthritis: Results from a Randomized, Double-Blind, Controlled Phase 3 Study
    Weinblatt, Michael
    Bingham, Clifton
    Burmester, Gerd
    Bykerk, V. P.
    Furst, Daniel E.
    Mariette, Xavier
    van der Heijde, Desiree
    Tatla, Daljit
    Arendt, Catherine
    Mountian, Irina
    VanLunen, Brenda
    Emery, Paul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [3] Reduction of Disease Burden on Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in DMARD-Naive Patients with Active, Severe, Progressive Rheumatoid Arthritis
    Bykerk, V. P.
    Bingham, Clifton
    Burmester, Gerd
    Furst, Daniel E.
    Mariette, Xavier
    Purcaru, Oana
    VanLunen, Brenda
    Weinblatt, Michael
    Emery, Paul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] Long-Term Maintenance of Response in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol
    Saraux, Alain
    Flipo, Rene-Marc
    Fagnani, Francis
    Cukierman, Gabrielle
    Bru, Isabelle
    Joubert, Jean-Michel
    Schuller, Jan-Christof
    Massol, Jacques
    Combe, Bernard
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] Remaining Pain in DMARD-Naive Rheumatoid Arthritis Patients Treated with Baricitinib and Methotrexate
    Lee, Yvonne C.
    Emery, Paul
    Bradley, John D.
    Zhu, Baojin
    Gaich, Carol L.
    Cai, Zhihong
    Quebe, Amanda
    Cardoso, Anabela
    Chen, Yun-Fei
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis
    Rannio, Tuomas
    Asikainen, Juha
    Kokko, Arto
    Hannonen, Pekka
    Sokka, Tuulikki
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (04) : 699 - 706
  • [7] Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients
    Roy Fleischmann
    Ronald F. van Vollenhoven
    Jiri Vencovský
    Rieke Alten
    Owen Davies
    Irina Mountian
    Marc de Longueville
    David Carter
    Ernest Choy
    [J]. Rheumatology and Therapy, 2017, 4 : 57 - 69
  • [8] Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients
    Fleischmann, Roy
    van Vollenhoven, Ronald F.
    Vencovsky, Jiri
    Alten, Rieke
    Davies, Owen
    Mountian, Irina
    de Longueville, Marc
    Carter, David
    Choy, Ernest
    [J]. RHEUMATOLOGY AND THERAPY, 2017, 4 (01) : 57 - 69
  • [9] IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY FOLLOWING 52 WEEKS OF TREATMENT WITH CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN DMARD-NAIVE PATIENTS WITH SEVERE, ACTIVE AND PROGRESSIVE RHEUMATOID ARTHRITIS: RESULTS FROM THE C -EARLY RANDOMIZED, DOUBLE-BLIND, CONTROLLED PHASE 3 STUDY
    Emery, P.
    Bingham, C.
    Burmester, G. R.
    Bykerk, V. P.
    Furst, D.
    Mariette, X.
    Purcaru, O.
    VanLunen, B.
    Weinblatt, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A710 - A710
  • [10] Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naive patients
    Wells, Alvin F.
    Edwards, Christopher J.
    Kivitz, Alan J.
    Bird, Paul
    Guerette, Benoit
    Delev, Nikolay
    Paris, Maria
    Teng, Lichen
    Aelion, Jacob A.
    [J]. RHEUMATOLOGY, 2022, 61 (03) : 1035 - 1043
12345